Curanex Pharmaceuticals Inc Common Stock (CURX) Stock Ticker
CURX right now
Market factors today
Unlock the full CURX picture
About Curanex Pharmaceuticals Inc Common Stock
Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their primary drug candidate, Phyto-N, is currently in development for a broad spectrum of health issues, including but not limited to ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. Established in 1996 and based in Jericho, New York, the company was formerly known as Fordman Pharma Inc. before adopting its current name in November 2023.
CURX stock facts
| Ticker symbol | CURX |
| Exchange | NASDAQ Global Select |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $6.7M |
| CEO | Jun Liu |
| Employees | 6 |
| Headquarters | Jericho, NY, US |
| IPO date | 2025-08-26 |
| Website | www.curanexpharma.com |
What you can see for CURX on Tickr
Live CURX price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the CURX report.
Rankings
FAQ
What is the ticker symbol for Curanex Pharmaceuticals Inc Common Stock?
The ticker symbol for Curanex Pharmaceuticals Inc Common Stock is CURX, listed on the NASDAQ Global Select.
What is CURX?
Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their primary drug candidate, Phyto-N, is currently in development for a broad spectrum of health issues, including but not limited to ulcerative colitis, atopic dermatitis, COVID-19, diabetes,…